Takashi Ishizu
Overview
Explore the profile of Takashi Ishizu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akiyama T, Iwazu Y, Usui J, Ebihara I, Ishizu T, Kobayashi M, et al.
Ther Apher Dial
. 2024 Sep;
29(2):178-188.
PMID: 39229751
Introduction: Recent studies have identified increased blood calciprotein particle (CPP) levels as risk factors for vascular calcification and cardiovascular events in patients undergoing maintenance hemodialysis. Although positively correlated with serum...
2.
Ishizu T
Yakugaku Zasshi
. 2024 Jun;
144(7):715-732.
PMID: 38945846
An aqueous solution of 2,3-cis gallate type catechin (-)-epigallocatechin-3-O-gallate (EGCg) and caffeine afforded a precipitate of Creaming-down Phenomenon, which crystallized slowly for about three months to give a colorless block...
3.
Ishizu T, Sato P, Tsuyama S, Nagao R, Fujiki K, Yamaji A
Anal Sci Adv
. 2024 May;
3(1-2):38-46.
PMID: 38716055
Under different concentrations of the base potassium deuteroxide KOD, the progress of reactions, such as enolization, D-substitution, isomerization, and conformational changes of diketopiperazine cyclo(L-Pro-L-Xxx) and cyclo(D-Pro-L-Xxx) (Xxx = Phe, Tyr)...
4.
Shimohata H, Usui J, Tawara-Iida T, Ebihara I, Ishizu T, Maeda Y, et al.
Clin Exp Nephrol
. 2024 Jan;
28(5):457-464.
PMID: 38238500
Background: Patients with end-stage kidney disease (ESKD) are at high risk of cardiovascular disease including stroke, heart failure, and ischemic heart disease (IHD). To prevent the occurrence and progression of...
5.
Ishizu T, Fujitani Y, Nishio R, Kamei H
Chem Pharm Bull (Tokyo)
. 2023 Nov;
71(11):804-811.
PMID: 37914258
The stoichiometry and precipitate yield of a complex of (-)-epigallocatechin-3-O-gallate (EGCg) and cyclo(Pro-Xxx) (Xxx = phenylalanine (Phe), tyrosine (Tyr)) were evaluated using integrated values of their proton signals by quantitative...
6.
Tomosugi N, Koshino Y, Ogawa C, Maeda K, Shimada N, Tomita K, et al.
Int J Mol Sci
. 2023 Sep;
24(18).
PMID: 37762085
Oral ferric citrate hydrate (FCH) is effective for iron deficiencies in hemodialysis patients; however, how iron balance in the body affects iron absorption in the intestinal tract remains unclear. This...
7.
Nagai K, Tawara T, Usui J, Ebihara I, Ishizu T, Kobayashi M, et al.
Front Nephrol
. 2023 Sep;
2:875207.
PMID: 37674990
Background: Immune dysfunction in hemodialysis patients is partially due to NK cell impairment. Ligands for NK activating receptors such as NKG2D expressed on cancer cells are involved in NK cell...
8.
Goromaru T, Fujita K, Mizumoto M, Ishizu T
Chem Pharm Bull (Tokyo)
. 2023 Feb;
71(2):134-139.
PMID: 36724976
A mixture of risperidone and eight major tea catechins: (-)-epicatechin-3-O-gallate (ECg), (-)-epigallocatechin-3-O-gallate (EGCg), (-)-catechin-3-O-gallate (Cg), (-)-gallocatechin-3-O-gallate (GCg), (-)-epicatechin (EC), (-)-epigallocatechin (EGC), (+)-catechin (CA), or (+)-gallocatechin (GC), in tartaric acid buffer...
9.
Tawara-Iida T, Usui J, Ebihara I, Ishizu T, Kobayashi M, Maeda Y, et al.
BMC Nephrol
. 2022 Mar;
23(1):104.
PMID: 35291986
Background: Patients with end-stage kidney disease (ESKD) face higher risks of life-threatening events including cardiovascular disease. Various risk factors are identified as agents influencing the life prognosis of ESKD patients....
10.
Ishizu T, Tokunaga M, Fukuda M, Matsumoto M, Goromaru T, Takemoto S
Chem Pharm Bull (Tokyo)
. 2021 Jun;
69(6):585-589.
PMID: 34078804
The addition of an aqueous solution of diketopiperazine cyclo(Pro-Xxx) (Xxx: amino acid residue) to an aqueous solution of (-)-epigallocatechin-3-O-gallate (EGCg) led to precipitation of the complex of EGCg and cyclo(Pro-Xxx)....